Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs) Meeting Abstract
| Authors: | Janku, F.; Heinrich, M.; Chi, P.; Razak, A. A.; von Mehren, M.; Gordon, M.; Ganjoo, K.; Trent, J.; Jones, R. L.; Gelderblom, H.; Running, K.; Wang, J.; Ruiz-Soto, R.; George, S. |
| Abstract Title: | Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs) |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900053 |
| DOI: | 10.1158/1538-7445.Am2019-ct058 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT058 -- S -- Source: Wos |
